Dr. Adrienne Phillips has been appointed as the director of cell therapy and bone marrow transplantation for the northern region at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. She will also serve as an associate professor of medicine at Rutgers Robert Wood Johnson Medical School. Her role will involve leading the cell therapy program in the northern region, which includes several medical centers in New Jersey. The program offers blood and marrow transplants for various types of cancer and is one of the only programs in the state certified to perform stem cell transplants. Phillips specializes in treating HTLV-Related Adult T-Cell Leukemia Lymphoma, a rare cancer that predominantly affects Latino and Caribbean Americans.
This appointment strengthens the cell therapy and bone marrow transplantation program at Rutgers Cancer Institute of New Jersey and allows for more accessible and comprehensive care for patients. The expertise of Dr. Phillips will enhance the program’s ability to provide lifesaving treatments closer to home. This is an important development considering the disproportionate impact of HTLV-Related Adult T-Cell Leukemia Lymphoma on Latino and Caribbean Americans. The appointment reflects the commitment of Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to prioritize patient care and collaboration among experts.
